US · LBRX
LB Pharmaceuticals Inc Common Stock
- Sector
- Healthcare · Biotechnology
- Headquarters
- New York, NY 10119
- Website
- lbpharma.us
Price · as of 2026-09-03
$47.52
Market cap 1.38B
Price history
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | — | — |
| P/E | -25.77 | |
| P/B | 2.16 | |
| P/S | — | |
| EV/EBITDA | -14.38 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $25.67 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| LBRX | LB Pharmaceuticals Inc Co… | $48.00 | 1.38B | — | — | -25.77 | 2.16 | — | -14.38 | — |
| ALT | Altimmune, Inc. | $3.03 | 267.42M | $18.06 | +496% | -3.50 | 1.37 | 7521.08 | -0.81 | 105.00% |
| ANNX | Annexon, Inc. | $5.37 | 879.83M | — | — | -4.25 | 4.15 | — | -3.26 | — |
| AURA | Aura Biosciences, Inc. | $7.18 | 460.95M | — | — | -3.38 | 2.62 | — | -2.21 | — |
| AUTL | Autolus Therapeutics plc | $1.90 | 505.67M | $41.85 | +2,102% | -1.33 | 2.15 | 5.07 | -1.73 | 646.68% |
| DBVT | DBV Technologies S.A. | $14.24 | 340.65M | — | — | -12.07 | 10.51 | — | -11.49 | — |
| DSGN | Design Therapeutics, Inc. | $13.57 | 847.54M | — | — | -8.31 | 2.73 | — | -5.23 | — |
| KRRO | Korro Bio, Inc. | $11.50 | 114.46M | $8.03 | -30% | -1.03 | 2.34 | 18.81 | -1.07 | 181.46% |
| LRMR | Larimar Therapeutics, Inc… | $4.10 | 425.92M | — | — | -2.02 | 4.29 | — | -1.22 | — |
| RCKT | Rocket Pharmaceuticals, I… | $3.50 | 382.18M | — | — | -2.36 | 1.90 | — | -1.72 | — |
| SLDB | Solid Biosciences Inc. | $8.73 | 859.47M | — | — | -3.67 | 3.55 | — | -2.74 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $47.52) − 1 = — (IC, example).